Sort by
Photocrosslinkable Chitosan–Nanocellulose Composite Hydrogels for Hemostatic, Antibacterial, and Soft-Tissue Biomedical Applications
Jhaleh Amirian
,Ehsan Amel Zendehdel
,Antons Sizovs
,Ingus Skadiņš
,Agnese Brangule
,Dace Bandere
Posted: 13 March 2026
Hydrogel-Forming Ability and Characterization of Exopolysaccharide (EPS) from Porphyridium cruentum for Wound Healing Applications
Marta M. Duarte
,Artem Suprinovych
,Anabela Veiga
,Ana I. Lopes
,Freni K. Tavaria
,Rui C. Morais
,Ana L. Oliveira
Marine exopolysaccharides (EPS) are emerging as sustainable bioactive polymers for biomedical hydrogels. Here, we report hydrogels from sulfated EPS produced by Porphyridium cruentum and ionically crosslinked with Ca²⁺, Ce³⁺, or Cu²⁺ to generate tunable networks for wound-healing applications. Rheological analysis showed that viscoelastic behavior was primarily governed by cation nature and accessible binding-site density, with diminishing gains above 2.5 wt% EPS and limited benefit beyond 10 wt% crosslinker. Ce³⁺ produced the most solid-like gel, Ca²⁺ yielded more thixotropic networks, and Cu²⁺ promoted rapid, heterogeneous crosslinking consistent with fast surface complexation. These network signatures translated into distinct in vitro performances. Cation selection tuned antibacterial activity against Staphylococcus aureus and Escherichia coli, with Cu²⁺ achieving rapid bactericidal effects and Ce³⁺ enabling an 8-log reduction after 24 h. Antioxidant capacity was assay-dependent (ABTS vs DPPH), reflecting combined EPS radical-quenching and metal-associated redox contributions. Conditioned-media assays using human dermal fibroblasts and keratinocytes indicated the most favorable cytocompatibility balance for Ce³⁺-crosslinked gels, whereas Cu²⁺ gels were limited by cytotoxicity. Macrophage cytokine readouts (TNF-α, IL-6) further supported formulation-dependent immunobiological activity. This work establishes microalgal EPS as a versatile polymer platform and links ionic crosslinking chemistry to rheological control and multifunctional biomedical performance.
Marine exopolysaccharides (EPS) are emerging as sustainable bioactive polymers for biomedical hydrogels. Here, we report hydrogels from sulfated EPS produced by Porphyridium cruentum and ionically crosslinked with Ca²⁺, Ce³⁺, or Cu²⁺ to generate tunable networks for wound-healing applications. Rheological analysis showed that viscoelastic behavior was primarily governed by cation nature and accessible binding-site density, with diminishing gains above 2.5 wt% EPS and limited benefit beyond 10 wt% crosslinker. Ce³⁺ produced the most solid-like gel, Ca²⁺ yielded more thixotropic networks, and Cu²⁺ promoted rapid, heterogeneous crosslinking consistent with fast surface complexation. These network signatures translated into distinct in vitro performances. Cation selection tuned antibacterial activity against Staphylococcus aureus and Escherichia coli, with Cu²⁺ achieving rapid bactericidal effects and Ce³⁺ enabling an 8-log reduction after 24 h. Antioxidant capacity was assay-dependent (ABTS vs DPPH), reflecting combined EPS radical-quenching and metal-associated redox contributions. Conditioned-media assays using human dermal fibroblasts and keratinocytes indicated the most favorable cytocompatibility balance for Ce³⁺-crosslinked gels, whereas Cu²⁺ gels were limited by cytotoxicity. Macrophage cytokine readouts (TNF-α, IL-6) further supported formulation-dependent immunobiological activity. This work establishes microalgal EPS as a versatile polymer platform and links ionic crosslinking chemistry to rheological control and multifunctional biomedical performance.
Posted: 13 March 2026
In Vitro Anti-Inflammatory and Anti-Diabetic Activities of Methanolic Extract of Sour Plum (Xymenia caffra) Leaves
Alifa Jacob
,Abiodun Dauda
,Vivian Okonkwo
,Nkechi Orji
,Andrew Ojonugwa
,Kindness Friday
This study evaluated the in vitro anti-inflammatory and antidiabetic activities of methanolic leaf extracts of Ximenia caffra (sour plum), a medicinal plant widely used in traditional healthcare systems across tropical Africa. Medicinal plants remain an important source of bioactive phytochemicals, and growing interest in phytopharmaceuticals has intensified the search for natural compounds with therapeutic potential. The present investigation aimed to scientifically validate the ethnomedicinal use of X. caffra leaves by assessing their enzyme inhibitory and anti-inflammatory properties. Fresh leaves of X. caffra were collected, authenticated, air-dried, pulverized, and extracted using methanol through maceration. Anti-inflammatory activity was determined using protein denaturation inhibition and membrane stabilization assays, while antidiabetic potential was evaluated through α-amylase and α-glucosidase enzyme inhibition assays. The extract exhibited concentration-dependent biological activities across all experimental models. Anti-inflammatory evaluation showed significant inhibition of protein denaturation and membrane stabilization, with IC₅₀ values of 129.83 µg/mL and 288.11 µg/mL, respectively. Similarly, the extract demonstrated appreciable antidiabetic activity, inhibiting α-amylase and α-glucosidase enzymes with IC₅₀ values of 227.01 µg/mL and 179.35 µg/mL, respectively, indicating stronger inhibition of α-glucosidase. These findings suggest that X. caffra leaves contain bioactive compounds capable of modulating inflammatory responses and carbohydrate-digesting enzymes, thereby supporting their traditional medicinal use. The study highlights the potential of X. caffra as a promising natural source for the development of plant-based anti-inflammatory and antidiabetic therapeutic agents.
This study evaluated the in vitro anti-inflammatory and antidiabetic activities of methanolic leaf extracts of Ximenia caffra (sour plum), a medicinal plant widely used in traditional healthcare systems across tropical Africa. Medicinal plants remain an important source of bioactive phytochemicals, and growing interest in phytopharmaceuticals has intensified the search for natural compounds with therapeutic potential. The present investigation aimed to scientifically validate the ethnomedicinal use of X. caffra leaves by assessing their enzyme inhibitory and anti-inflammatory properties. Fresh leaves of X. caffra were collected, authenticated, air-dried, pulverized, and extracted using methanol through maceration. Anti-inflammatory activity was determined using protein denaturation inhibition and membrane stabilization assays, while antidiabetic potential was evaluated through α-amylase and α-glucosidase enzyme inhibition assays. The extract exhibited concentration-dependent biological activities across all experimental models. Anti-inflammatory evaluation showed significant inhibition of protein denaturation and membrane stabilization, with IC₅₀ values of 129.83 µg/mL and 288.11 µg/mL, respectively. Similarly, the extract demonstrated appreciable antidiabetic activity, inhibiting α-amylase and α-glucosidase enzymes with IC₅₀ values of 227.01 µg/mL and 179.35 µg/mL, respectively, indicating stronger inhibition of α-glucosidase. These findings suggest that X. caffra leaves contain bioactive compounds capable of modulating inflammatory responses and carbohydrate-digesting enzymes, thereby supporting their traditional medicinal use. The study highlights the potential of X. caffra as a promising natural source for the development of plant-based anti-inflammatory and antidiabetic therapeutic agents.
Posted: 11 March 2026
Innovative Use of Cereals and Starch-Rich By-Products in Single-Cell Protein Production: Opportunities and Challenges
Olumide Joseph Olubiyo
,Sungil Ferreira
Posted: 09 March 2026
High-Resolution 3D Bioprinted Hydrogel Scaffolds Enable Sustained Intraperitoneal Cell Delivery
Yu Zhang
,Lauren E. Carlberg
,Alain Valdivia
,Morrent Thang
,Caroline A. Stockwell
,Jillian L. Perry
,Shawn D. Hingtgen
Posted: 09 March 2026
Structural Characterization and Sustainability Assessment of a Natural Bioactive Compound Using the SAES Framework
Ali Güneş
,Aylin Erdoğdu
,Farshad Ganji
,Hamed Kioumarsi
Posted: 09 March 2026
Between Surprises and Novelties: Benzyl Triphenyl Phosphonium Bromide Is Bactericidal Against MRSA and Inhibits Biofilm Formation with Minimal Cytotoxicity
Silvana Alfei
,Gabriella Piatti
,Guendalina Zuccari
,Caterina Reggio
,Anna Maria Schito
Background. Quaternary phosphonium salts (QPSs) are extensively researched since represent new promising weapons to counteract critical superbugs, regardless their robust pattern of resistance. Methods. Here, dynamic light scattering analysis was carried out on QPSs 1, 3 and 4 recently reported and already found active against cancer cells, and phosphine 2 unveiling particles of 700-800 nm for 2, 3 and 4 and positive Zeta-potential (ζ-p ) for all (+4.2-+38.1 mV). 1, 3 and 4 plus 2, were microbiologically evaluated, assessing minimum inhibitory concentration values (MICs) (1-4), time-killing curves (1), and anti-biofilm capacity (1). Results. MICs on a total of 23 Gram-positive and Gram-negative clinically isolated superbugs, evidenced that, poorly soluble 2, 3 and 4 exhibited not reproducible MICs, while 1 provided interesting MICs, which made it worthy of further investigations. In fact, 1 was active against clinically relevant multidrug-resistant (MDR) Gram-positive species and not active against MDR Gram-negative species including Pseudomonas aeruginosa. Specifically, MICs = 16-32 µg/mL and 16-64 µg/mL were determined against methicillin-resistant Staphylococcus aureus (MRSA) and S. epidermidis (MRSE) respectively. MICs = 32-64 µg/mL were observed against teicoplanin- and vancomycin-resistant (VRE) Enterococcus faecalis and E. faecium and no activity against P. aeruginosa (> 128 µg/mL). Notably, time-kill experiments established that 1 was bactericidal against MRSA, while strongly inhibited (up to 100%) the formation of biofilm produced by the strongest biofilm-producers S. epidermidis and S. aureus isolates of our collection, at MICs and 2.5 × MIC concentrations, depending on isolates considered. Interestingly, if used against Staphylococci, and mainly MRSA, 1 was softly haemolytic. It was no cytotoxic against not tumorigenic human keratinocytes (HaCaT) and murine embryonic fibroblasts (3T3) in all cases. Structure-activity relationships have been studied, leading to outcomes which could be of great help for designing optimized new QPSs. Conclusions. Findings of this study overturn previous antimicrobial reports on compound 1, suggesting it as a new excellent weapon to counteract bacterial resistance and biofilm production by MRSA and MRSE superbugs, as well as thinkable for future in vivo experiments and clinical development.
Background. Quaternary phosphonium salts (QPSs) are extensively researched since represent new promising weapons to counteract critical superbugs, regardless their robust pattern of resistance. Methods. Here, dynamic light scattering analysis was carried out on QPSs 1, 3 and 4 recently reported and already found active against cancer cells, and phosphine 2 unveiling particles of 700-800 nm for 2, 3 and 4 and positive Zeta-potential (ζ-p ) for all (+4.2-+38.1 mV). 1, 3 and 4 plus 2, were microbiologically evaluated, assessing minimum inhibitory concentration values (MICs) (1-4), time-killing curves (1), and anti-biofilm capacity (1). Results. MICs on a total of 23 Gram-positive and Gram-negative clinically isolated superbugs, evidenced that, poorly soluble 2, 3 and 4 exhibited not reproducible MICs, while 1 provided interesting MICs, which made it worthy of further investigations. In fact, 1 was active against clinically relevant multidrug-resistant (MDR) Gram-positive species and not active against MDR Gram-negative species including Pseudomonas aeruginosa. Specifically, MICs = 16-32 µg/mL and 16-64 µg/mL were determined against methicillin-resistant Staphylococcus aureus (MRSA) and S. epidermidis (MRSE) respectively. MICs = 32-64 µg/mL were observed against teicoplanin- and vancomycin-resistant (VRE) Enterococcus faecalis and E. faecium and no activity against P. aeruginosa (> 128 µg/mL). Notably, time-kill experiments established that 1 was bactericidal against MRSA, while strongly inhibited (up to 100%) the formation of biofilm produced by the strongest biofilm-producers S. epidermidis and S. aureus isolates of our collection, at MICs and 2.5 × MIC concentrations, depending on isolates considered. Interestingly, if used against Staphylococci, and mainly MRSA, 1 was softly haemolytic. It was no cytotoxic against not tumorigenic human keratinocytes (HaCaT) and murine embryonic fibroblasts (3T3) in all cases. Structure-activity relationships have been studied, leading to outcomes which could be of great help for designing optimized new QPSs. Conclusions. Findings of this study overturn previous antimicrobial reports on compound 1, suggesting it as a new excellent weapon to counteract bacterial resistance and biofilm production by MRSA and MRSE superbugs, as well as thinkable for future in vivo experiments and clinical development.
Posted: 06 March 2026
Plant-Based Biomaterials as Bioinstructive Immunomodulators: Design Principles, Mechanisms, and Translational Challenges
Stefania Lamponi
Posted: 04 March 2026
Network Silsesquioxane-Based Organogel/Silicone Composites for the Long-Lasting Delivery of Nitric Oxide
Kyle D. Hallowell
,Fatima Naser Aldine
,Hope N. Vonder Brink
,Ashley K. Mockensturm
,Hitesh Handa
,Elizabeth J. Brisbois
,Alexis D. Ostrowski
,Joseph C. Furgal
Posted: 03 March 2026
Cytotoxicity of Self-Etch Versus Etch-and-Rinse Dentin Adhesives: A Screening Study II
Kamelia Parkhoo
,Lea Aylin Schmitz
,Luisa Fröb
,Nicole Gruessner
,Georgios Romanos
,Eva Hermann
,Susanne Gerhardt-Szép
Posted: 27 February 2026
Alginate–Chitosan Biopolymer Nanoparticles for Efficient Bacteriophage Encapsulation and Transport
Patricia Dolores Martinez-Flores
,Joselyn Aime García-Mar
,Jose Manuel García-Perez
,David Encinas-Basurto
,Gerardo García-González
,Gerardo Rodea
,Marco Antonio López Mata
,Antonio Topete
,Josué Juárez
Posted: 27 February 2026
A Comprehensive Review of Polysaccharide-Based Bioinks for 3D Bioprinting: Analyzing Structure–Property–Processing Relationships and Addressing Translational Challenges
Sakhi Tayeb
Posted: 27 February 2026
Porcine Skin–Derived Reconstituted Lipid Nanoparticles Intrinsically Boost Fibroblast Proliferation and Migration
Xiangyan Liao
,Cheng Wang
Posted: 26 February 2026
Cyclic Olefin Copolymer with Noble Metal Nanostructures as Antibacterial Material
Petr Slepička
,Jonáš Priškin
,Bára Frýdlová
,Petr Sajdl
,Václav Švorčík
,Anna Kutová
,Petr Malinsky
,Zdeněk Hrdlička
,Ondřej Kvítek
,Nikola Slepičková Kasálková
Posted: 26 February 2026
Composite Materials Based on Sodium Alginate and Synthetic Powders of Calcium Carbonate
Marat M. Akhmedov
,Tatiana V. Safronova
,Arina A. Pavlova
,Olga A. Kibardina
,Tatiana B. Shatalova
,Vadim B. Platonov
,Albina M. Murashko
,Yaroslav Y. Filippov
,Egor A. Motorin
,Olga T. Gavlina
+4 authors
Posted: 26 February 2026
Glycopolymers as a Tool for Specific Surface Modification of Polymeric Biomaterials
Joachim Storsberg
,Sophia Rosencrantz
,Ruben R. Rosencrantz
Posted: 26 February 2026
Effect of Gamma Irradiation and Simulated Physiological Conditions on the Physicochemical Properties of 3D-Printed Medical-Grade βTCP Composite
Elham Seifi
,Sacha Cavelier
,Kerr D. G. Samson
,Dietmar W. Hutmacher
Posted: 26 February 2026
Advanced Guar Gum/Polyvinyl Alcohol/MnP-Based Smart Hydrogel for Promoting Osteoblastic Proliferation
Karen Guillén-Carvajal
,Benjamín Valdez-Salas
,Jorge Salvador-Carlos
,Jimena Chairez-González
,Ernesto Beltrán-Partida
,Mario Curiel-Alvarez
Posted: 26 February 2026
Thermal and Morphological Effect of Low Tenor Alkali Treatment on Flax and Hemp Fibre Scraps: A Parametric Study
Sonila Xhafa
,Lorenzo Pietracci
,Roberto Giacomantonio
,Fabio Marchetti
,Vincenzo Castorani
,Marco Antonini
,Roberto Gunnella
,Sara Mattiello
,Cristiano Fragassa
,Carlo Santulli
Posted: 09 February 2026
Development and Characterization of Reinforced Flexible Packaging Based on Amazonian Cassava Starch Through Flat Sheet Extrusion
Johanna Garavito
,Sofía Castellanos
,Clara P. Peña-Venegas
,Diego A. Castellanos
Posted: 09 February 2026
of 46